Overall, these results indicate that both age and BMI are consistently associated with reduced concentrations of FGF-19 and FGF-22, particularly in patients with type 2 diabetes, whereas FGF-2 and FGF-23 showed no consistent correlations with either parameter. This evidence concerns the gene FGF19 and type 2 diabetes mellitus.